Results of a phase 3 study of elderly patients with newly diagnosed AML treated with sapacitabine and decitabine administered in alternating cycles Meeting Abstract
| Authors: | Kantarjian, H. M.; Begna, K. H.; Altman, J. K.; Goldberg, S. L.; Sekeres, M. A.; Strickland, S. A.; Rubenstein, S. E.; Arellano, M. L.; Claxton, D. F.; Baer, M. R.; Gautier, M.; Berman, E.; Seiter, K.; Solomon, S. R.; Schiller, G. J.; Luger, S.; Butrym, A.; Gaidano, G.; Thomas, X.; Montesinos, P.; Rizzieri, D. A.; Quick, D. P.; Agura, E.; Venugopal, P.; Subramanian, J.; Maness, L. J.; Robert, D. E.; Hicheri, Y.; Kadia, T.; Ravandi, F.; Buyse, M. E.; Chiao, J. |
| Abstract Title: | Results of a phase 3 study of elderly patients with newly diagnosed AML treated with sapacitabine and decitabine administered in alternating cycles |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419402141 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.891.891 |
| Notes: | Meeting Abstract: 891 -- Source: Wos |
